LeMaitre Vascular, Inc. (LeMaitre), a provider of peripheral vascular devices and implants, has extended its distribution agreement with Endologix, Inc (Endologix) for Endologix Powerlink System in 12 European countries through June 30, 2013. The Powerlink System is an endoluminal stent graft for the minimally invasive treatment of abdominal aortic aneurysms. Distribution had previously been set to expire on December 31, 2010.
LeMaitre Vascular currently distributes the Powerlink System in twelve European countries, including Germany, France and the UK, among others.
Since 2007 when LeMaitre Vascular began offering the Powerlink System, this bifurcated stent graft has proven to be a complimentary addition to our TAArget thoracic and UniFit abdominal endografts in Europe, said George W. LeMaitre, chairman and chief executive officer. We are excited to continue offering this product line to our customers.
Endologix develops and manufactures minimally invasive treatments for aortic disorders.